PharmacoEconomics
Collection
Collection
- ISSN: 11707690
- https://link.springer.com/journal/40273
Published by ADI BV
-
Standardizing the inclusion of indirect medical costs in economic evaluations Article
PharmacoEconomics, 29(3), 175-187.P.H.M. van Baal (Pieter), A. Wong (Albert), L.C. Slobbe (Laurentius C.), J.J. Polder (Johan), W.B.F. Brouwer (Werner) and G.A. de Wit (Ardine)
February 2011 -
PAID 1.0 in practice: A brief clarification regarding its possibilities and limitations Article
PharmacoEconomics, 29(6), 545-547.May 2011 -
Do productivity costs matter?: The impact of including productivity costs on the incremental costs of interventions targeted at depressive disorders Article
PharmacoEconomics, 29(7), 601-619.H.M. Krol (Marieke), J. Papenburg (Joc), M.A. Koopmanschap (Marc) and W.B.F. Brouwer (Werner)
June 2011 -
Unit costs for delivery of antiretroviral treatment and prevention of mother-to-child transmission of HIV: A systematic review for low- and middle-income countries Review
O. Galrraga (Omar), V.J. Wirtz (Veronika), A. Figueroa-Lara (Alejandro), Y. Santa-Ana-Tellez (Yared), I. Coulibaly (Ibrahima), K.M. Viisainen (Kirsi), A. Medina-Lara (Antonieta) and E.L. Korenromp (Eline)
June 2011 -
Utility estimation in chronic obstructive pulmonary disease: A preference for change? Article
PharmacoEconomics, 29(11), 917-932.J. Petrillo (Jennifer), F.E. van Nooten (Floortje), P. Jones (Peter) and M.P.M.H. Rutten-van Mölken (Maureen)
October 2011 -
Willingness to pay for adverse drug event regulatory actions Article
PharmacoEconomics, 29(11), 963-975.J.C. Bouvy (Jacoline), J. Weemers (Just), H. Schellekens (Huub) and M.A. Koopmanschap (Marc)
October 2011 -
Preference-Based Health-Related Quality-of-Life Outcomes in Children with Autism Spectrum Disorders: A Comparison of Generic Instruments Article
PharmacoEconomics, 30(8), 661-679.J.M. Tilford (John Mick), N. Payakachat (Nalin), E.M. Kovacs (Erica), J.M. Pyne (Jeffrey), W.B.F. Brouwer (Werner), T.G. Nick (Todd), J. Bellando (Jayne) and K.A. Kuhlthau (Karen)
January 2012 -
Cost effectiveness of treatment with new agents in advanced non-small-cell lung cancer: A systematic review Review
M.L. Bongers (Mathilda), V.M.H. Coupé (Veerle), B.M. Jansma (Bernadette), E.F. Smit (Egbert) and C.A. Uyl-de Groot (Carin)
January 2012